Publications

Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

 118
Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential

Tags:

Previous Article

Interplay between mesothelial and immune cells in the tumor microenvironment

Next Article

LSD analogue with potential for treating schizophrenia

Related Posts

Structural basis for hepatitis B virus restriction by a viral receptor homologue

Structural basis for hepatitis B virus restriction by a...

 86

Impaired vasopressin neuromodulation of the lateral septum leads to social behavior deficits in Shank3B+/- male mice

Impaired vasopressin neuromodulation of the lateral sep...

 59

Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes

Lethal COVID-19 associates with RAAS-induced inflammati...

 67